Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Period Ended December 31, 2023
Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve unaudited financial results for the period ended December 31, 2023 Solara Active Pharma Sciences Ltd - 541540 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Scrutinizer Report and Voting Result Solara Active Pharma Sciences Ltd - 541540 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizer Report and Voting Result Solara Active Pharma Sciences Ltd - 541540 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 Solara Active Pharma Sciences Ltd - 541540 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on January 08, 2024 for Pronomz Ventures LLP Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 08, 2024 for Pronomz Ventures LLP Solara Active Pharma Sciences Ltd - 541540 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on January 08, 2024 for Pronomz Ventures LLP Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 08, 2024 for Pronomz Ventures LLP Solara Active Pharma Sciences Ltd - 541540 - Closure of Trading Window
Closure of Trading Window Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Devicam Capital LLP & Others